Literature DB >> 29410367

Identification of a small molecule inhibitor of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] using mixture-based combinatorial libraries.

Tung Tran1, Kevin Chiem1, Saumya Jani1, Brock A Arivett2, David L Lin1, Rupali Lad1, Verónica Jimenez1, Mary B Farone3, Ginamarie Debevec4, Radleigh Santos4, Marc Giulianotti4, Clemencia Pinilla5, Marcelo E Tolmasky6.   

Abstract

The aminoglycoside, 6'-N-acetyltransferase type Ib [AAC(6')-Ib] is the most widely distributed enzyme among AAC(6')-I-producing Gram-negative pathogens and confers resistance to clinically relevant aminoglycosides, including amikacin. This enzyme is therefore an ideal target for enzymatic inhibitors that could overcome resistance to aminoglycosides. The search for inhibitors was carried out using mixture-based combinatorial libraries, the scaffold ranking approach, and the positional scanning strategy. A library with high inhibitory activity had pyrrolidine pentamine scaffold and was selected for further analysis. This library contained 738,192 compounds with functionalities derived from 26 different amino acids (R1, R2 and R3) and 42 different carboxylic acids (R4) in four R-group functionalities. The most active compounds all contained S-phenyl (R1 and R3) and S-hydromethyl (R2) functionalities at three locations and differed at the R4 position. The compound containing 3-phenylbutyl at R4 (compound 206) was a robust enzymatic inhibitor in vitro, in combination with amikacin it potentiated the inhibition of growth of three resistant bacteria in culture, and it improved survival when used as treatment of Galleria mellonella infected with aac(6')-Ib-harboring Klebsiella pneumoniae and Acinetobacter baumannii strains.
Copyright © 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Acetyltransferase; Aminoglycoside; Combinatorial libraries; ESKAPE; Enterobacteriaceae; Hospital infection

Mesh:

Substances:

Year:  2018        PMID: 29410367      PMCID: PMC6592615          DOI: 10.1016/j.ijantimicag.2018.01.019

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  4 in total

1.  Amikacin in combination with zinc pyrithione prevents growth of a multidrug-resistant carbapenem-resistant Klebsiella pneumoniae isolate.

Authors:  Jesus Magallon; Peter Vu; Craig Reeves; Stella Kwan; Kimberly Phan; Crista L Oakley-Havens; María Soledad Ramirez; Marcelo E Tolmasky
Journal:  Int J Antimicrob Agents       Date:  2021-09-20       Impact factor: 15.441

2.  Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc.

Authors:  Jesus Magallon; Kevin Chiem; Tung Tran; Maria S Ramirez; Veronica Jimenez; Marcelo E Tolmasky
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

3.  Small Klebsiella pneumoniae Plasmids: Neglected Contributors to Antibiotic Resistance.

Authors:  Maria S Ramirez; Andrés Iriarte; Rodrigo Reyes-Lamothe; David J Sherratt; Marcelo E Tolmasky
Journal:  Front Microbiol       Date:  2019-09-20       Impact factor: 5.640

4.  Aminoglycoside 6'-N-acetyltransferase Type Ib [AAC(6')-Ib]-Mediated Aminoglycoside Resistance: Phenotypic Conversion to Susceptibility by Silver Ions.

Authors:  Craig M Reeves; Jesus Magallon; Kenneth Rocha; Tung Tran; Kimberly Phan; Peter Vu; Yang Yi; Crista L Oakley-Havens; José Cedano; Verónica Jimenez; Maria S Ramirez; Marcelo E Tolmasky
Journal:  Antibiotics (Basel)       Date:  2020-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.